Case report: aspergillus infection on residual limb wound

  • Vũ Thu Trang Bệnh viện Trung ương Quân đội 108
  • Trần Lê Linh Trang Bệnh viện Trung ương Quân đội 108
  • Trần Trung Đức Bệnh viện Trung ương Quân đội 108
  • Nguyễn Mạnh Linh Bệnh viện Trung ương Quân đội 108
  • Lưu Ngọc Vi Bệnh viện Trung ương Quân đội 108
  • Lê Thị Lài Tâm Bệnh viện Trung ương Quân đội 108
  • Nguyễn Thị Lệ Ngọc Bệnh viện Trung ương Quân đội 108
  • Nguyễn Đăng Nam Bệnh viện Trung ương Quân đội 108

Main Article Content

Keywords

Aspergillus; surgical site infection; amputation stump; trauma, voriconazole; itraconazole.

Abstract

Invasive cutaneous and soft-tissue aspergillosis is rare, usually confined to the superficial layers but occasionally extending into deeper tissues and internal organs, particularly in immunocompromised patients. However, it may also occur in immunocompetent individuals, especially after trauma, burns, or surgery; among these, post-surgical invasive aspergillosis (PSIA) is very uncommon and often underrecognized. This report describes a healthy female patient who developed Aspergillus sp. infection at a transfemoral amputation stump after a traffic accident. The diagnosis was confirmed by positive culture of necrotic tissue on Sabouraud dextrose agar and histopathology (H&E, PAS) demonstrating branching hyphae invading the tissue. Management included surgical debridement, split-thickness skin autografting, and systemic antifungal therapy (intravenous voriconazole for 1 week followed by oral itraconazole for 5 months). After 5 months, the stump healed with good scarring and no recurrent necrosis. This case highlights the importance of considering invasive fungal infection in contaminated wounds and combining culture and histopathology with surgical and systemic antifungal therapy.

Article Details

References

1. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA et al (2008) Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clinical infectious diseases 46(3): 327-360.
2. Pasqualotto AC, Denning DW (2006) Post-operative aspergillosis. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 12(11): 1060-1076.
3. Patterson TF, Thompson GR, Denning DW, Fishman JA, Hadley S, Herbrecht R et al (2016) Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 63(4): 1-60.
4. Pérez Cortés Villalobos A, Alahmadi G, Rotstein C (2025) Brief Report on Primary Cutaneous Invasive Aspergillosis in a Patient With Prolonged Neutropenia Following a Traumatic Injury. Open Forum Infectious Diseases 12(4):ofaf140.
5. Nguyen V, Truong T (2023) Invasive aspergillosis in trauma patients: beyond immunocompromised hosts. Clin Microbiol Infect 29(4): 200-208.
6. Alquraish FA, AlQattan AS, Al-Shammari T (2023) Surgical site invasive aspergillosis in immunocompetent patient secondary to Kramericeae herb: Case report. International Journal of Surgery Case Reports 105: 108026.
7. Giacobbe DR, Riccardi N, Vena A, Bassetti M (2020) Mould Infections of Traumatic Wounds: A Brief Narrative Review. Infectious Diseases and Therapy 9(1):1-15.
8. Mori T, Watanabe K, Ito K, Inamatsu T, Ikemoto H (1992) Clinical efficacy of itraconazole for systemic aspergillosis: Multicentre study in Japan. Chemotherapy 38(1): 53. doi:10.1159/000239069.
9. De Beule K, De Doncker P, Cauwenbergh G, Koster M, Legendre R, Blatchford N, Daunas J, Chwetzoff E (1988) The Treatment of Aspergillosis and Aspergilloma with Itraconazole, Clinical Results of an Open International Study (1982-1987). Mycoses 31(9): 476-485.
10. Drummond RA, Desai JV, Ricotta EE, Swamydas M, Deming C, Conlan S et al (2022) Long-term antibiotic exposure promotes mortality after systemic fungal infection by driving lymphocyte dysfunction and systemic escape of commensal bacteria. Cell host & microbe 30(7): 1020-1033.